glp-1 production Glucagon-Like Peptide-1 Based Therapies: A

1998 (Eur J Endocrinol) Type Preclinical characterization Subjects Rats and swine Key Finding Defined ipamorelin as a selective GH secretagogue

Injectable hair protocol: 12 mg daily or 5 days/week , minimum 1624 weeks , cycle 8 weeks on / 4 weeks off Topical scalp protocol: 0.5 % solution , 12 ml twice daily to thinning areas, 6 months before meaningful assessment Enhanced hair protocol: GHK-Cu topical + 0.5 mm derma-roll 12/week + minoxidil + finasteride (where appropriate) - the full "big-3 + peptide" stack we routinely prescribe alongside FUE hair transplant in Mumbai 3

Many suitable candidates have experienced significant antipsychotic-associated weight gain, prediabetes, or established type 2 diabetes while remaining psychiatrically stable

AACR 29:368, 1988

Research peptides cost significantly less but come with purity concerns and legal gray areas